Calcium Phosphate and Incretins

Not Applicable

Completed

• Conditions: Healthy Men
• Interventions: Dietary Supplement: calcium phosphate; Other: placebo

• Registration Number: NCT01296997
• Lead Sponsor: University of Jena

Brief Summary

The study was conducted to investigate the effect of a calcium phosphate supplementation on the secretion of incretins.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07
• Primary Completion: 2010-09
• Study Completion: 2010-09
• Study First Submitted: 2011-02-15
• Study First Submitted QC: 2011-02-15
• Study First Posted: 2011-02-16
• Status Verified: 2012-11
• Last Update Submitted: 2012-11-06
• Last Update Posted: 2012-11-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 10

Inclusion Criteria

• healthy men

Exclusion Criteria

• intake of dietary supplements and chronic diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
calcium phosphate	calcium phosphate	-
placebo	placebo	-

Primary Outcome Measures

Name	Time	Method
secretion of incretins	3 weeks

Secondary Outcome Measures

Name	Time	Method
concentration of minerals in plasma	3 weeks

Trial Locations

Locations (1)

Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Physiology; 🇩🇪 Jena, Thuringia, Germany